Locations:
March 11, 2022/Cancer/Surgical Oncology

Hybrid Resection of a Fast-Growing Dumbbell Schwannoma: A Case Study

Two-day procedure prevents neurologic compromise for octogenarian

21-CNR-2573159-CQD-Hero-650×450

An 82-year-old woman presented to Cleveland Clinic with right shoulder pain. An MRI of the spine revealed an incidental left paravertebral mass measuring 4.2 cm in maximal direction. There was extension into the T3 intervertebral foramen with remodeling of the adjacent vertebrae.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Because of the relative lack of symptoms on the left and the patient’s concern about having a major surgery at her age, she consulted with the spine team and decided on observation,” says Daniel Raymond, MD, a thoracic surgeon in the Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic.

A mass can be seen pushing the patient’s spinal cord to the right. The tumor extends through the neuroforamen from the outside and into the spinal canal.

Schwannoma surveillance

During the surveillance period, the patient began to develop pain over her left scapula. She underwent physical therapy, but the pain continued intermittently. Seventeen months after her initial MRI, repeat imaging showed significant extension of the schwannoma into the spinal canal, with compression of the thecal sac and contact with the spinal cord.

“Typically, you wouldn’t expect to see a dramatic change in a schwannoma in only a year or so,” says Dr. Raymond. “In this case, the tumor was pushing on the patient’s spine, causing symptoms and growing relatively quickly.” He and Richard Schlenk, MD, a neurosurgeon and Neurosurgery Residency Training Program Director at Cleveland Clinic, decided that a hybrid resection of the dumbbell-shaped schwannoma was the best course of action.

Surgical solution

Dr. Schlenk performed a T2-3 laminectomy using a standard posterior approach to the spinal component of the paravertebral mass. The following day, Dr. Raymond performed robotic thoracic surgery on the remaining intrathoracic component, encircling and removing the mass located on top of the aorta.

Advertisement

The surgeons opted for a two-day procedure due to the patient’s age and her concerns about the recovery process.

“The stress on the system can be a lot for an octogenarian, so we do the spine surgery first and allow the patient to recover overnight,” explains Dr. Raymond. “This approach gives us an opportunity to medically optimize our patients before putting them through a second significant operation.”

The patient in this case had an uncomplicated postoperative course and was discharged home on day four. Pathology results confirmed a grade 1 spinal schwannoma. Her long-term prognosis is excellent.

Team approach

Dr. Raymond credits the success of the surgery to collaboration among the multidisciplinary team. “We have a great system. It’s not about the individual surgeon: It’s the team and culture,” he says.

Working in tandem, clinicians from thoracic surgery and neurosurgery charted a course to treat the patient based on her physiological status, not her chronological age.

“So often, we see people in our clinic who have been told they are too old for surgery,” says Dr. Raymond. “A person like this patient is clearly a candidate for surgery. We gave her an excellent operation and prevented her from serious neurologic compromise. She did great.”

Advertisement

Related Articles

Patient and doctor
October 9, 2026/Cancer/News & Insight

First Radioligand Therapy Approved for Metastatic Hormone-Sensitive Prostate Cancer

Adding 177Lu-PSMA-617 to ADT plus an ARPI cut the risk of radiographic progression or mortality by 28%

Woman running
October 7, 2026/Cancer/Patient Support

Pilot Project Aids Cancer Survivors in Achieving Healthy Weight and Reducing Recurrent Risk

New program will help patients improve fitness and manage weight after cancer treatment

Dr Keith McCrae
October 6, 2026/Cancer/Benign Hematology

How is ITP Therapy Evolving?

Cleveland Clinic hematologist highlights new guidelines and treatment advances in immune thrombocytopenia

Bone metastasis
October 5, 2026/Cancer/Innovations

Digital Platform Cuts Bone Metastasis Treatment Decision Time

NIMBLE replaces weekly tumor board delays with same-day multidisciplinary recommendations

Prostate cancer
October 2, 2026/Cancer/Radiation Oncology

ArteraAI Prostate Biomarker Accurate Across Diverse Populations

Cleveland Clinic study provides validation for the test, which combines AI and pathological data to predict outcomes in postoperative patients

Prostate cancer illustration
October 1, 2026/Cancer/Radiation Oncology

PSMA PET Scan-Guided LDR Brachytherapy Can Control Localized Prostate Cancer Recurrence

Advanced imaging technology catches metastases much earlier, allowing treatment with fewer side effects

Throat cancer
September 30, 2026/Cancer/Radiation Oncology

Same Cure Rate, Less Radiation in HPV-Associated Oral Cancer

Reduced radiation for lymph node areas reduces side effects

Lung cancer illustration
September 29, 2026/Cancer/Radiation Oncology

Single-Fraction SBRT Shows Comparable Outcomes to Three-Fraction Approach in Early-Stage Lung Cancer

Large Cleveland Clinic analysis may help resolve a longstanding question over optimal fractionation

Ad